Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Wegener's granulomatosis patients show an adequate antibody response to influenza vaccination.

Holvast A, Stegeman CA, Benne CA, Huckriede A, Wilschut JC, Palache AM, Kallenberg CG, Bijl M.

Ann Rheum Dis. 2009 Jun;68(6):873-8. doi: 10.1136/ard.2008.092924. Epub 2008 Jul 14. Erratum in: Ann Rheum Dis. 2009 Sep;68(9):1516.

PMID:
18625625
2.

Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.

Holvast A, van Assen S, de Haan A, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.

Rheumatology (Oxford). 2009 Oct;48(10):1294-9. doi: 10.1093/rheumatology/kep200. Epub 2009 Aug 19.

PMID:
19692457
3.

Cell-mediated immune responses to influenza vaccination in Wegener's granulomatosis.

Holvast A, de Haan A, van Assen S, Stegeman CA, Huitema MG, Huckriede A, Benne CA, Westra J, Palache A, Wilschut J, Kallenberg CG, Bijl M.

Ann Rheum Dis. 2010 May;69(5):924-7. doi: 10.1136/ard.2009.112813. Epub 2009 Jul 12.

PMID:
19596692
4.

High disease activity: an independent factor for reduced immunogenicity of the pandemic influenza a vaccine in patients with juvenile systemic lupus erythematosus.

Campos LM, Silva CA, Aikawa NE, Jesus AA, Moraes JC, Miraglia J, Ishida MA, Bueno C, Pereira RM, Bonfa E.

Arthritis Care Res (Hoboken). 2013 Jul;65(7):1121-7. doi: 10.1002/acr.21948.

5.

Protective effect of A/H1N1 vaccination in immune-mediated disease--a prospectively controlled vaccination study.

Adler S, Krivine A, Weix J, Rozenberg F, Launay O, Huesler J, Guillevin L, Villiger PM.

Rheumatology (Oxford). 2012 Apr;51(4):695-700. doi: 10.1093/rheumatology/ker389. Epub 2011 Dec 14.

6.

Serological response to the 2009 H1N1 influenza vaccination in patients with inflammatory bowel disease.

Cullen G, Bader C, Korzenik JR, Sands BE.

Gut. 2012 Mar;61(3):385-91. doi: 10.1136/gutjnl-2011-300256. Epub 2011 Jul 13.

PMID:
21757451
7.

Randomized trial investigating the safety and efficacy of influenza vaccination in patients with antineutrophil cytoplasmic antibody-associated vasculitis.

Jeffs LS, Peh CA, Jose MD, Lange K, Hurtado PR.

Nephrology (Carlton). 2015 May;20(5):343-51. doi: 10.1111/nep.12416.

PMID:
25656094
8.

Reduced seroprotection after pandemic H1N1 influenza adjuvant-free vaccination in patients with rheumatoid arthritis: implications for clinical practice.

Ribeiro AC, Guedes LK, Moraes JC, Saad CG, Aikawa NE, Calich AL, França IL, Carvalho JF, Sampaio-Barros PD, Goncalves CR, Borba EF, Timenetsky Mdo C, Precioso AR, Duarte A, Bonfa E, Laurindo IM.

Ann Rheum Dis. 2011 Dec;70(12):2144-7. doi: 10.1136/ard.2011.152983. Epub 2011 Aug 22.

PMID:
21859696
9.

Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.

Holvast A, Huckriede A, Wilschut J, Horst G, De Vries JJ, Benne CA, Kallenberg CG, Bijl M.

Ann Rheum Dis. 2006 Jul;65(7):913-8. Epub 2005 Dec 1.

10.

Damage caused by Wegener's granulomatosis and its treatment: prospective data from the Wegener's Granulomatosis Etanercept Trial (WGET).

Seo P, Min YI, Holbrook JT, Hoffman GS, Merkel PA, Spiera R, Davis JC, Ytterberg SR, St Clair EW, McCune WJ, Specks U, Allen NB, Luqmani RA, Stone JH; WGET Research Group.

Arthritis Rheum. 2005 Jul;52(7):2168-78.

11.

Leucocyte membrane expression of proteinase 3 correlates with disease activity in patients with Wegener's granulomatosis.

Muller Kobold AC, Kallenberg CG, Tervaert JW.

Br J Rheumatol. 1998 Aug;37(8):901-7.

PMID:
9734683
12.

Improved serological response to H1N1 monovalent vaccine associated with viral suppression among HIV-1-infected patients during the 2009 influenza (H1N1) pandemic in the Southern Hemisphere.

Maruszak H, Jeganathan S, Smith DE, Robertson P, Barnes T, Furner V.

HIV Med. 2012 Jul;13(6):352-7. doi: 10.1111/j.1468-1293.2011.00987.x. Epub 2012 Feb 2.

14.

Antibody response to inactivated subunit influenza vaccine in patients with Wegener's granulomatosis.

Zycinska K, Romanowska M, Nowak I, Rybicka K, Wardyn KA, Brydak LB.

J Physiol Pharmacol. 2007 Nov;58 Suppl 5(Pt 2):819-28.

15.

Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients.

Lertdumrongluk P, Changsirikulchai S, Limkunakul C, Prachukthum P, Punpiput P, Buppanharun R, Chotpitayasunondh C.

Vaccine. 2012 Feb 1;30(6):1108-14. doi: 10.1016/j.vaccine.2011.12.023. Epub 2011 Dec 15.

PMID:
22178515
16.

H1N1 vaccination in pediatric renal transplant patients.

Kelen K, Ferenczi D, Jankovics I, Varga M, Molnar MZ, Sallay P, Reusz G, Langer RM, Pasti K, Gerlei Z, Szabo AJ.

Transplant Proc. 2011 May;43(4):1244-6. doi: 10.1016/j.transproceed.2011.03.072.

PMID:
21620100
17.

Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.

Zuccotti GV, Scaramuzza A, Riboni S, Mameli C, Pariani E, Tanzi E, Zanetti A, Radaelli G.

Vaccine. 2009 Aug 27;27(39):5357-62. doi: 10.1016/j.vaccine.2009.06.082. Epub 2009 Jul 14.

PMID:
19607951
18.

Etanercept combined with conventional treatment in Wegener's granulomatosis: a six-month open-label trial to evaluate safety.

Stone JH, Uhlfelder ML, Hellmann DB, Crook S, Bedocs NM, Hoffman GS.

Arthritis Rheum. 2001 May;44(5):1149-54.

19.

Effective seroconversion and safety following the pandemic influenza vaccination (anti-H1N1) in patients with juvenile idiopathic arthritis.

Aikawa NE, Campos LM, Goldenstein-Schainberg C, Saad CG, Ribeiro AC, Bueno C, Precioso AR, Timenetsky Mdo C, Silva CA, Bonfá E.

Scand J Rheumatol. 2013;42(1):34-40. doi: 10.3109/03009742.2012.709272. Epub 2012 Sep 20.

PMID:
22992045
20.

IgG subclass distribution, affinity of anti-myeloperoxidase antibodies in sera from patients with Wegener's granulomatosis and microscopic polyangiitis.

Liu LJ, Chen M, Yu F, Zhao MH, Wang HY.

Nephrology (Carlton). 2008 Oct;13(7):629-35. doi: 10.1111/j.1440-1797.2008.00976.x. Epub 2008 Sep 3.

PMID:
18775059

Supplemental Content

Support Center